[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Genmab is acquiring Merus for $X billion, sparking high community engagement and positive sentiment. Engagements hit a 52-week high of XXXXXXX for the day, indicating strong interest in the project.
A cryptocurrency project.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXXX +18%
1 Month: XXXXXXX +191%
1-Year High: XXXXXXX on 2025-10-06
1-Year Low: XXX on 2025-08-02
Social Network | X |
---|---|
Engagements | XXXXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +24%
1-Year High: XXX on 2025-06-27
1-Year Low: XX on 2025-04-27
Social Network | X |
---|---|
Mentions | XXX |
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $gmab in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +68%
1-Year High: XXX on 2025-06-27
1-Year Low: XX on 2025-04-27
The most influential creators that mention $gmab in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@BiopharmIQ | X | XXXXXX | X | XXXXX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +22%
1 Month: XX% +9%
1-Year High: XXX% on 2025-05-10
1-Year Low: XX% on 2025-09-14
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXX | XX% | XXX | XX% | XX | X% |
Total | XXX | XX% | XXX | XX% | XX | X% |
Top assets mentioned In the posts about $gmab in the last XX hours
Merus N.V. Common Shares (MRUS) AstraZeneca PLC (AZN) Novo-Nordisk (NVO) Pfizer, Inc. (PFE) Bitcoin Incognito (XBI) Johnson & Johnson (JNJ) BioMarin Pharmaceutical, Inc. (BMRN) Merck & Co., Inc. (MRK) Advanced Micro Devices (AMD) Alphabet Inc Class A (GOOGL)
Top topics mentioned In the posts about $gmab in the last XX hours
$gmabco, $mrus, stocks healthcare, stocks, $8b, stocks technology, acquisition, investment, stocks financial services, $azn, $nvo, $pfe, stocks banks, stocks industrials, stocks communication services, $xbi, ticker, $97share, johnson johnson, nasdaq, $bmrn, stocks consumer cyclical, $mrk, longterm, money, danish krone, coins made in usa, advanced micro devices, bloomberg, $argx, $googl, quarterly earnings, $nvda, novo, $novcde, $ggndf, $hsbc, $smci, regeneron pharmaceuticals inc, stocks bitcoin treasuries, $abbv, $wolf, $jnj, united states dollar, $psnl, gsk plc, taiwan semiconductor, $elan, $cnc, $elv, $cve, $issc, $pypl, coins defi, $hca, $unh, $bntx, denmark, $bbio, $hrmy, $onc, coins stablecoin, $urgn, $incy, $jazz, $oco, $uec, has been, $uex, $1b, 1b, $bcas, $qure, surge, $dwtx, launches, pharma, people with, $novo, $eqnrol, $llys, $kgc, $danskeco, $zealco, $ttwo, $tdw, $pags, $talk, $uber, $ddog, $ftnt, ipo, $zura, $anab, $path, vertex protocol, $lac, $ltbr, $tmc, $ual
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Weekly Review: $AMD $SANM $GMAB $MRUS $NVO $AKRO $DRD $AU $GFI $IE $SSRM $BE $OKLO $LEU $USAR $MP $IREN $CIFR $WULF $UUUU $METC $UEC $MLYS $PTGX $ABVX $APLD $ASTS $IONQ $LEU $NBIS $NTLA $QBTS $RGTI $AAPL $ALAB @MartyChargin ðŦ"
X Link @sssc 2025-10-11T23:14Z 3203 followers, XXX engagements
"Sounds like you're eyeing $GMAB closely. Recent acquisition of Merus has boosted the stock XX% this month. Darzalex sales look strong per analysts with Q3 earnings due Nov X. PDUFA for Epkinly in 2L+ FL is Nov 30could be a catalyst. Acasunlimab NSCLC trials advancing OS data expected by year-end. Always DYOR ð"
X Link @grok 2025-10-10T13:21Z 6.4M followers, XXX engagements
"$GMAB Cowen expect Darzalex to meet/beat $3.6B consensus ests vs our $XXX conservatively model Q3 Epkinly net sales of $105M vs cons. $124M. Kesimpta should beat. Tepezza likely to be weak. Rybrevant should continue to grow well. Acasunlimab 2L+ NSCLC update on OS by YE25. Nov XX 2025 PDUFA for 2L+ FL and Ph3 1L/2L DLBCL"
X Link @semodough 2025-10-10T13:12Z 41.4K followers, 2695 engagements
"ðĒM&A News: Novo Nordisk to acquire Akero Therapeutics for up to $5.2B ðĻ ð° $54/share cash + $6/share CVR tied to FDA approval of efruxifermin for MASH cirrhosis ð XX% premium to Akeros pre-deal price ð§Ž Adds Phase X FGF21 analog EFX to Novos metabolic portfolio ð Deal closes by YE 2025 pending approvals ðĪ Signals renewed M&A momentum in MASH/NASH. Validates FGF21 pathway.potential re-rating for peers like $VKTX $TERN See image for more details"
X Link @BiopharmIQ 2025-10-09T15:06Z 27.3K followers, 15.9K engagements